
Executive Director, Future Go-to-Market (GTM) Transformation
Scorpion Therapeutics, New Bremen, Ohio, United States
Role Summary
The Executive Director of Future Go-to-Market (GTM) Transformation leads the vision and activation of Novartis’ next-generation Go-to-Market engagement model. This role guides a dynamic team of Directors, each driving a key workstream – from customer targeting and engagement to field role design and future capabilities. Together, they shape a unified, customer-centered approach that aligns with brand priorities and commercial goals across therapeutic areas. As the central connector, this leader fosters collaboration, governance, and innovation to bring future-ready Go-to-Market strategies to life. Responsibilities
Design the future-state Go-to-Market (GTM) model for Novartis, ensuring it reflects customer-centric thinking, system-wide integration, and alignment across all therapeutic areas. Turn strategic vision into clear, scalable action plans across five transformation domains: customer targeting, engagement models, field role design, capabilities, and metrics. Align Go-to-Market transformation efforts with brand strategy, therapeutic area goals, U.S. commercial priorities, and customer engagement objectives. Lead and support five Director-level workstream leaders, fostering clarity, ownership, and collaboration across initiatives. Build strong governance practices, track milestones, and ensure seamless cross-functional coordination. Collaborate with senior leaders in Medical, Market Access, Marketing, People & Organization, and Strategy to co-create and embed transformation efforts. Represent Go-to-Market transformation in enterprise-wide forums, promoting transparency and connection between field teams and headquarters. Engage stakeholders across the organization to build understanding, drive adoption, and sustain momentum for change. Guide the development, testing, and scaling of new Go-to-Market models that respond to evolving market needs and customer expectations. Inspire a culture of innovation, teamwork, and customer focus – encouraging bold ideas and breakthrough results. Qualifications
Required: Bachelor’s degree required from 4-year college or university. Required: 10+ years’ experience in life sciences, healthcare, technology, or other complex business-to-business (B2B) industries. Required: Deep knowledge of commercial strategy, enterprise transformation, or Go-to-Market (GTM) design. Required: Proven ability to attract, grow, and retain diverse talent while building high-performing, inclusive teams. Required: Strong cross-functional leadership and collaboration skills across varied teams and stakeholders. Required: Strategic thinker with sharp analytical skills and experience leading major initiatives and managing budgets. Required: Successful track record of driving changes in matrixed, regulated environments with solid operational and financial acumen. Preferred: MBA degree, with experience in regulated or complex business-to-business (B2B) industries such as but not limited to pharmaceuticals, biotechnology, technology, financial services, or consulting. Preferred: Familiarity with agile methodologies, transformation frameworks, and enterprise planning tools that support scalable change.
#J-18808-Ljbffr
The Executive Director of Future Go-to-Market (GTM) Transformation leads the vision and activation of Novartis’ next-generation Go-to-Market engagement model. This role guides a dynamic team of Directors, each driving a key workstream – from customer targeting and engagement to field role design and future capabilities. Together, they shape a unified, customer-centered approach that aligns with brand priorities and commercial goals across therapeutic areas. As the central connector, this leader fosters collaboration, governance, and innovation to bring future-ready Go-to-Market strategies to life. Responsibilities
Design the future-state Go-to-Market (GTM) model for Novartis, ensuring it reflects customer-centric thinking, system-wide integration, and alignment across all therapeutic areas. Turn strategic vision into clear, scalable action plans across five transformation domains: customer targeting, engagement models, field role design, capabilities, and metrics. Align Go-to-Market transformation efforts with brand strategy, therapeutic area goals, U.S. commercial priorities, and customer engagement objectives. Lead and support five Director-level workstream leaders, fostering clarity, ownership, and collaboration across initiatives. Build strong governance practices, track milestones, and ensure seamless cross-functional coordination. Collaborate with senior leaders in Medical, Market Access, Marketing, People & Organization, and Strategy to co-create and embed transformation efforts. Represent Go-to-Market transformation in enterprise-wide forums, promoting transparency and connection between field teams and headquarters. Engage stakeholders across the organization to build understanding, drive adoption, and sustain momentum for change. Guide the development, testing, and scaling of new Go-to-Market models that respond to evolving market needs and customer expectations. Inspire a culture of innovation, teamwork, and customer focus – encouraging bold ideas and breakthrough results. Qualifications
Required: Bachelor’s degree required from 4-year college or university. Required: 10+ years’ experience in life sciences, healthcare, technology, or other complex business-to-business (B2B) industries. Required: Deep knowledge of commercial strategy, enterprise transformation, or Go-to-Market (GTM) design. Required: Proven ability to attract, grow, and retain diverse talent while building high-performing, inclusive teams. Required: Strong cross-functional leadership and collaboration skills across varied teams and stakeholders. Required: Strategic thinker with sharp analytical skills and experience leading major initiatives and managing budgets. Required: Successful track record of driving changes in matrixed, regulated environments with solid operational and financial acumen. Preferred: MBA degree, with experience in regulated or complex business-to-business (B2B) industries such as but not limited to pharmaceuticals, biotechnology, technology, financial services, or consulting. Preferred: Familiarity with agile methodologies, transformation frameworks, and enterprise planning tools that support scalable change.
#J-18808-Ljbffr